Literature DB >> 21421581

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).

Mariana Castanheira, Rodrigo E Mendes, Leah N Woosley, Ronald N Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21421581     DOI： 10.1093/jac/dkr081

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  29 in total

1.  Expansion of clonal complex 258 KPC-2-producing Klebsiella pneumoniae in Latin American hospitals: report of the SENTRY Antimicrobial Surveillance Program.

Authors:  Mariana Castanheira; Andrew J Costello; Lalitagauri M Deshpande; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2012-03       Impact factor: 5.191

Review 2.  Management of antimicrobial use in the intensive care unit.

Authors:  Francisco Álvarez-Lerma; Santiago Grau
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

3.  Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.

Authors:  Mariana Castanheira; Helio S Sader; David J Farrell; Rodrigo E Mendes; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

4.  Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets.

Authors:  Rodrigo E Mendes; Mariana Castanheira; Leah N Woosley; Gregory G Stone; Patricia A Bradford; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

5.  Rapid Flow Cytometry Test for Identification of Different Carbapenemases in Enterobacteriaceae.

Authors:  Ana P Silva; Isabel Faria-Ramos; Elisabete Ricardo; Isabel M Miranda; Maria J Espinar; Sofia Costa-de-Oliveira; Rafael Cantón; Acácio G Rodrigues; Cidália Pina-Vaz
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

6.  In Vitro Evaluation of the Activity of Imipenem-Relebactam against 451 Recent Clinical Isolates of Bacteroides Group and Related Species.

Authors:  David R Snydman; Nilda V Jacobus; Laura A McDermott
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

7.  Regional resistance surveillance program results for 12 Asia-Pacific nations (2011).

Authors:  Rodrigo E Mendes; Myrna Mendoza; Kirnpal K Banga Singh; Mariana Castanheira; Jan M Bell; John D Turnidge; Stephen S F Lin; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

8.  Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011.

Authors:  Helio S Sader; Robert K Flamm; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

9.  Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.

Authors:  Jasmine Ahmed-Bentley; A Uma Chandran; A Mark Joffe; Desiree French; Gisele Peirano; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

10.  Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America.

Authors:  Christine Lascols; Gisele Peirano; Meredith Hackel; Kevin B Laupland; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.